Difference between revisions of "Duff SE, et al. FASEB J. (2003) cited as Ref 745 in DOI: 10.1038/s41392-020-0110-5 (Q10008)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: PubMed ID (P140): 12773481, #quickstatements; #temporary_batch_1590001671040)
(‎Created claim: Fourth Author string (P152): Kumar S, #quickstatements; #temporary_batch_1590155310798)
 
(5 intermediate revisions by the same user not shown)
Property / Publication Date
 +
2003
Timestamp+2003-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2003 / rank
 +
Normal rank
Property / Published In Name String
 +
FASEB J.
Property / Published In Name String: FASEB J. / rank
 +
Normal rank
Property / Volume
 +
17
Property / Volume: 17 / rank
 +
Normal rank
Property / title
 +
CD105 is important for angiogenesis: evidence and potential applications (English)
Property / title: CD105 is important for angiogenesis: evidence and potential applications (English) / rank
 +
Normal rank
Property / Page(s)
 +
984-992
Property / Page(s): 984-992 / rank
 +
Normal rank
Property / Fourth Author string
 +
Kumar S
Property / Fourth Author string: Kumar S / rank
 +
Normal rank

Latest revision as of 13:50, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Duff SE, et al. FASEB J. (2003) cited as Ref 745 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Duff SE
    0 references
    Li C
    0 references
    Garland JM
    0 references
    0 references
    2003
    0 references
    FASEB J.
    0 references
    17
    0 references
    CD105 is important for angiogenesis: evidence and potential applications (English)
    0 references
    984-992
    0 references
    Kumar S
    0 references